Related Experiment Video
Updated: May 9, 2026

06:11
Culturing Primary Rat Inner Medullary Collecting Duct Cells
Published on: June 21, 2013
Culturing primary rat inner medullary collecting duct cells
Dörte Faust1, Andrea Geelhaar, Beate Eisermann
1Anchored Signalling, Max-Delbrück-Center for Molecular Medicine.
Journal of Visualized Experiments : Jove
|July 16, 2013
Summary
This study introduces a method for culturing primary rat inner medullary collecting duct cells. These cells, expressing vasopressin V2 receptors and aquaporin-2, are vital for studying water reabsorption and related diseases.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Biology
Background:
- Arginine-vasopressin (AVP) regulates body water homeostasis by promoting water reabsorption in renal collecting ducts.
- AVP signaling involves vasopressin V2 receptors (V2R), cAMP production, and aquaporin-2 (AQP2) phosphorylation and translocation.
- Dysregulation of AVP signaling causes conditions like diabetes insipidus and is linked to cardiovascular diseases.
Purpose of the Study:
- To present a protocol for cultivating primary rat inner medullary collecting duct (IMCD) cells.
- To establish a model system for investigating the molecular mechanisms controlling AQP2.
- To identify novel drug targets for diseases related to disrupted water reabsorption.
Main Methods:
- Isolation of primary IMCD cells from rat renal inner medullae.
- Cultivation of IMCD cells for 6–8 days post-seeding.
- Utilizing standard cell culture techniques in dishes, flasks, and micro-titer plates.
Main Results:
- Primary rat IMCD cells endogenously express V2R and AQP2.
- The established cell culture protocol is efficient and suitable for standard laboratories.
- The cells serve as a viable model for studying AVP-mediated water reabsorption.
Conclusions:
- Primary rat IMCD cells provide a valuable tool for studying AVP-regulated water reabsorption.
- This protocol facilitates research into molecular mechanisms controlling AQP2.
- The model system aids in the discovery of therapeutic targets for water balance disorders.

